Avid Bioservices Inc (CDMO)

[PPHMVERYLONG]

WHY WE ARE AT $1.50:



1) NO DRUG CURRENTLY APPROVED.


2) LOSES TEN OF MILLIONS EVERY YEAR.


3) NO LATE STAGE RESULTS TO BE RELEASED ANYTIME SOON.


4) ONLY ONE DRUG IN DEVELOPMENT AND THAT DRUG HAS NEVER HAD A SUCESSFULL BEYOND QUESTION LATE STAGE TRIAL(STAGE TWO OR GREATER).

5) NO PARTNER TO FUND PLANNED EXPANSION(YOU KNOW WHAT THAT MEANS) DILUTION HERE I COME.


QUESTION: WHAT HAS HAPPENDED IN 2015 THAT WOULD MAKE A PARTNER COME ABOARD NOW:


1) PRE-CLINICAL DATA- PLEASE NOT WHILE I AM EATING.


2) MSK COLLABORATION- NICE TO HAVE BUT WILL HARDLY CONVINCE SOMEONE TO FORK UP $100,000,000 PLUS. AGAIN, YOU NEED A SUCCESSFULL LATE STAGE TRIAL TO DO THAT.

ANYONE NOTICE THAT THE PIPELINE ON THE WEBSITE HAS BEEN UPDATED. APPARENTLY, WE NO LONGER HAVE ANY ONGOING PHASE II TRIALS. IT IS GOING TO BE YEARS, FACE IT. I KNOW, I HAVE WAITED SIXTEEN.